Correlation Between Immunic and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immunic and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunic and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunic and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Immunic and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunic with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunic and Apellis Pharmaceuticals.
Diversification Opportunities for Immunic and Apellis Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Immunic and Apellis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Immunic and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Immunic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunic are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Immunic i.e., Immunic and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immunic and Apellis Pharmaceuticals
Given the investment horizon of 90 days Immunic is expected to generate 1.09 times more return on investment than Apellis Pharmaceuticals. However, Immunic is 1.09 times more volatile than Apellis Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.2 per unit of risk. If you would invest 109.00 in Immunic on December 5, 2024 and sell it today you would earn a total of 8.00 from holding Immunic or generate 7.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Immunic vs. Apellis Pharmaceuticals
Performance |
Timeline |
Immunic |
Apellis Pharmaceuticals |
Immunic and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunic and Apellis Pharmaceuticals
The main advantage of trading using opposite Immunic and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunic position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |